PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 21, 2026Pest Management Science0 citations

Discovery of novel uridine‐based chitin synthase inhibitors: Design, synthesis and structure–activity relationships

View Full Paper
XLXiangyang LvBLBin LiuHFHanghang Fu

Key Points

  • The study aims to identify novel uridine-based chitin synthase inhibitors (CHSIs) for antifungal applications.
  • Designed and synthesized thirty-three novel uridine-based derivatives through fragment-based drug design.
  • Conducted bioassays to evaluate antifungal efficacy against Alternaria alternata and Botrytis cinerea.
  • Established a 3D-QSAR model to analyze structure-activity relationships and aid in compound optimization.
  • Compound 5a exhibited superior fungicidal activity with an EC50 of 0.78 μg mL−1, outperforming polyoxin B (EC50 = 46.56 μg mL−1).
  • Demonstrated significant CHS inhibitory activity with an IC50 of 1.47 μg mL−1 compared to polyoxin B (IC50 = 1.84 μg mL−1).
  • Exhibited low toxicity in zebrafish and did not significantly affect mung bean seed germination.

Abstract

Abstract Background Chitin synthase (CHS) enables the construction of fungi cell wall and insect skeleton by catalyzing the formation of chitin. CHS inhibitor (CHSI) disrupts the integrity of these structural barriers, leading to fungal cell lysis. Notably, CHSIs are considered non‐toxic to vertebrates, making CHS a promising target for the development of novel antifungal agents. Results Thirty‐three novel uridine‐based derivatives (UDs) were designed and synthesized through fragment‐based drug design (FBDD) to discover potential CHSIs. Bioassays demonstrated that most of the synthesized compounds exhibited excellent fungicidal activity against Alternaria alternata and Botrytis cinerea , with inhibition rates exceeding 80% at 100 μg mL − 1 . Specifically, compound 5a showed significantly stronger fungicidal activity (EC 50 = 0.78 μg mL − 1 ) than the commercial CHSI fungicide polyoxin B (EC 50 = 46.56 μg mL − 1 ). In vivo antifungal assays revealed that compound 5a effectively suppressed the infection of Alternaria alternata and Botrytis cinerea , outperforming the positive control. SEM and TEM analyses indicated that compound 5a disrupted the fungal cell wall and membrane. Enzyme inhibition assays confirmed that compound 5a exhibited superior CHS inhibitory activity (IC 50 = 1.47 μg mL − 1 ) compared to polyoxin B (IC 50 = 1.84 μg mL − 1 ), and molecular docking simulations demonstrated a stronger binding affinity of compound 5a to CHS relative to polyoxin B. A 3D‐QSAR model was established to elucidate the structure–activity relationships (SARs) and provide guidance for further structural optimization. Toxicity tests showed that compound 5a had no significant inhibitory effect on mung bean seed germination and exhibited low toxicity to zebrafish. Conclusion Compound 5a is a promising antifungal agent with a unique mechanism of action by targeting fungal CHS. This study discovered a series of novel CHSIs with excellent fungicidal activities, offering valuable candidates for fungicide development. © 2026 Society of Chemical Industry.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lv et al. (2026) studied this question.

synapsesocial.com/papers/6a0ea15cbe05d6e3efb5ff8chttps://doi.org/10.1002/ps.70933
Ask AI
Helpful
Bookmark
Share
View Full Paper